Back
Oncternal Therapeutics 10K Form
Sell
35
ONCT
Oncternal Therapeutics
Last Price:
1.19
Seasonality Move:
21.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ONCT News And Ratings
See the #1 stock for the next 7 days that we like better than ONCT
ONCT Financial Statistics
Sales & Book Value
| Annual Sales: | $4.32M |
|---|---|
| Cash Flow: | $-5.82M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.32 |
| Price / Book: | 0.24 |
Profitability
| EPS (TTM): | -12.15000 |
|---|---|
| Net Income (TTM): | $-35.97M |
| Gross Margin: | $13.44M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Oncternal Therapeutics Earnings Forecast
Key Oncternal Therapeutics Financial Ratios
Oncternal Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ONCT |
| CUSIP: | 68236P |
| Website: | oncternal.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ONCT Technical Analysis vs Fundamental Analysis
Sell
35
Oncternal Therapeutics (ONCT)
is a Sell
Is Oncternal Therapeutics a Buy or a Sell?
-
Oncternal Therapeutics stock is rated a Sell
The current Oncternal Therapeutics [ONCT] share price is $1.29. The Score for ONCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.